These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3010164)

  • 1. Modulation of catecholamine transmission and sleep in man.
    Nicholson AN; Pascoe PA; Stone BM
    Neuropharmacology; 1986 Mar; 25(3):271-4. PubMed ID: 3010164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man.
    Nicholson AN; Pascoe PA
    Neuropharmacology; 1986 Oct; 25(10):1079-83. PubMed ID: 2946975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission.
    Nicholson AN; Belyavin AJ; Pascoe PA
    Neuropsychopharmacology; 1989 Jun; 2(2):131-43. PubMed ID: 2568115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor.
    Nicholson AN; Pascoe PA
    Neuropharmacology; 1988 Jun; 27(6):597-602. PubMed ID: 3262203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis, catecholamines, rapid eye movement sleep and aggressive behaviour.
    Carlini EA; Lindsey CJ; Tufik S
    Br J Pharmacol; 1977 Nov; 61(3):371-9. PubMed ID: 201320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of sleep by trimipramine in man.
    Nicholson AN; Pascoe PA; Turner C
    Eur J Clin Pharmacol; 1989; 37(2):145-50. PubMed ID: 2792167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histaminergic systems and sleep. Studies in man with H1 and H2 antagonists.
    Nicholson AN; Pascoe PA; Stone BM
    Neuropharmacology; 1985 Mar; 24(3):245-50. PubMed ID: 2859543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.
    Lelkes Z; Obál F; Benedek G; Rubicsek G; Alföldi P; Obál F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):149-53. PubMed ID: 3561528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some atypical antidepressants on catecholamine synthesis and release.
    Raiteri M; Maura G; Cerrito F
    Adv Biochem Psychopharmacol; 1982; 31():199-209. PubMed ID: 6282055
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic transmission and the sleep-wakefulness continuum in man.
    Nicholson AN; Pascoe PA
    Neuropharmacology; 1990 Apr; 29(4):411-7. PubMed ID: 2160627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mianserin on noradrenergic transmission in the rat anococcygeus muscle.
    Doggrell SA
    Br J Pharmacol; 1980 Feb; 68(2):241-50. PubMed ID: 6244037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mianserin blocks alpha 2 adrenoceptors in submucous neurones of the guinea-pig caecum.
    Tokimasa T; Ariyoshi M; Akasu T
    Eur J Pharmacol; 1987 Nov; 143(2):243-50. PubMed ID: 2446891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.
    Scheller D; Dürmüller N; Moser P; Porsolt RD
    Eur J Pharmacol; 2008 Apr; 584(1):111-7. PubMed ID: 18304531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mianserin on human sleep.
    Maeda Y; Hayashi T; Furuta H; Kim Y; Morikawa K; Ishiguro N; Ueno K; Sano J; Yamaguchi N
    Neuropsychobiology; 1990-1991; 24(4):198-204. PubMed ID: 2135711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral cortex injury: effect of blockers of re-uptake of catecholamines.
    Mondeh JD; Olenik C; Götz E; Uhl A; Meyer DK
    Eur J Pharmacol; 1993 Aug; 240(1):39-44. PubMed ID: 8405120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of anticonvulsant drugs with mianserin and nomifensine.
    Nawishy S; Hathway N; Turner P
    Lancet; 1981 Oct; 2(8251):871-2. PubMed ID: 6116980
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of amphetamine, diazepam and caffeine on polysomnography (EEG, EMG, EOG)-derived variables measured using telemetry in Cynomolgus monkeys.
    Authier S; Bassett L; Pouliot M; Rachalski A; Troncy E; Paquette D; Mongrain V
    J Pharmacol Toxicol Methods; 2014; 70(1):86-93. PubMed ID: 24878255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of nomifensine: a review of studies in healthy subjects.
    Siegfried K; Taeuber K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):33-8. PubMed ID: 6370972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.